Etiological factors of facial nerve stimulation in cochlear implant users

   Cochlear implantation is a high-tech method of rehabilitation of persons with complete deafness. However, cochlear implantation in patients may be accompanied by a number of difficulties due to the peculiarities of the structure of the cochlea, the relative position of anatomical structures relative to it and the nature of the acquired pathology of the inner ear. The reaction of the facial nerve during stimulation of one of the electrodes of the cochlear implant system is a common complication that can lead to a deterioration in the patient’s quality of life due to significant discomfort and restrictions on the use of the cochlear implant system. The debut of twitching of facial muscles in patients after cochlear implantation can occur both at the stage of connecting the speech processor and at the stages of further rehabilitation, which according to world literature can reach an interval of 10 years from the moment of surgery. Anatomical features of the cochlea, its interposition with the facial nerve, changes in the bone labyrinth, further progression of remodeling or ossification of the cochlea play a significant role in the development of symptoms of facial nerve stimulation in patients with sensorineural hearing loss of the IV degree, including at the stage of subsequent settings of the speech processor. The frequency of occurrence of this complication in various literature sources varies from 1 to 14.9 %. The purpose of this work is to review the world literature on the etiology of facial nerve stimulation in users of cochlear implants, highlighting the main theories of the origin of non-auditory sensations in this category of patients, since the data conducted in various studies are variable, and with a certain etiology reaches 38 %.

1. Berrettini S., Vito de A., Bruschini L., Passetti S., Forli F. Facial nerve stimulation after cochlear implantation: our experience. Acta Otorhinolaryngol Ital. 2011; 31 (1): 11-16. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146332.

2. Bigelow D. C., Kay D. J., Rafter K. O., Montes M., Knox G. W., Yousem D. M. Facial nerve stimulation from cochlear implants. Am J Otol. 1998; 19 (2): 163-169. Available at: https://pubmed.ncbi.nlm.nih.gov/9520052.

3. Rayner M. G., King T., Djalilian H. R., Smith S., Levine S. C. Resolution of facial stimulation in otosclerotic cochlear implants. Otolaryngol Head Neck Surg. 2003; 129 (5): 475-480. https://doi.org/10.1016/s0194-59980301444-x.

4. Rotteveel L. J., Proops D. W., Ramsden R. T., Saeed S. R., van Olphen A. F., Mylanus E. A. Cochlear implantation in 53 patients with otosclerosis: demographics, computed tomographic scanning, surgery, and complications. Otol Neurotol. 2004; 25 (6): 943-952. https://doi.org/10.1097/00129492-200411000-00014.

5. Tavakoli M., Jalilevand N., Kamali M., Modarresi Y., Zarandy M. M. Language sampling for children with and without cochlear implant: MLU, NDW, and NTW. Int J Pediatr Otorhinolaryngol. 2015; 79 (12): 2191-2195. https://doi.org/10.1016/j.ijporl.2015.10.001.

6. Kelsall D. C., Shallop J. K., Brammeier T. G., Prenger E. C. Facial nerve stimulation after Nucleus 22-channel cochlear implantation. Am J Otol. 1997; 18 (3): 336-341. Available at: https://pubmed.ncbi.nlm.nih.gov/9149828.

7. Niparko J. K., Oviatt D. L., Coker N. J., Sutton L., Waltzman S. B., Cohen N. L. Facial nerve stimulation with cochlear implantation. VA Cooperative Study Group on Cochlear Implantation. Otolaryngol Head Neck Surg. 1991; 104 (6): 826-830. https://doi.org/10.1177/019459989110400610.

8. Weber B. P., Lenarz T., Battmer R. D., Hartrampf R., Dahm M. C., Dietrich B. Otosclerosis and facial nerve stimulation. Ann Otol Rhinol Laryngol Suppl. 1995; 166: 445-447. Available at: https://pubmed.ncbi.nlm.nih.gov/7668746.

9. Muckle R. P., Levine S. C. Facial nerve stimulation produced by cochlear implants in patients with cochlear otosclerosis. Am J Otol. 1994; 15 (3): 394-398. Available at: https://pubmed.ncbi.nlm.nih.gov/8579147.

10. Rah Y. C., Yoon Y. S., Chang M. Y., Lee J. Y., Suh M. W., Lee J. H. et al. Facial nerve stimulation in the narrow bony cochlear nerve canal after cochlear implantation. Laryngoscope. 2016; 126 (6): 1433-1439. https://doi.org/10.1002/lary.25655.

11. Aljazeeri I. A., Khurayzi T., Al- Amro M., Alzhrani F., Alsanosi A. Evaluation of computed tomography parameters in patients with facial nerve stimulation post-cochlear implantation. Eur Arch Otorhinolaryngol. 2021; 278 (10): 3789-3794. https://doi.org/10.1007/s00405-020-06486-7.

12. Cushing S. L., Papsin B. C., Gordon K. A. Incidence and characteristics of facial nerve stimulation in children with cochlear implants. Laryngoscope. 2006; 116 (10): 1787-1791. https://doi.org/10.1097/01.mlg.0000231303.85828.20.

13. Papsin B. C. Cochlear implantation in children with anomalous cochleoves-tibular anatomy. Laryngoscope. 2005; 115 (Suppl. 106): 1-26. https://doi.org/10.1097/00005537-200501001-00001.

14. Horner K. C. The effect of sex hormones on bone metabolism of the otic capsule - an overview. Hear Res. 2009; 252 (1-2): 56-60. https://doi.org/10.1016/j.heares.2008.12.004.

15. Kempf H. G., Johann K., Lenarz T. Complications in pediatric cochlear implant surgery. Eur Arch Otorhinolaryngol. 1999; 256 (3): 128-132. https://doi.org/10.1007/s004050050124.

16. Ahn J. H., Oh S. H., Chung J. W., Lee K. S. Facial nerve stimulation after cochlear implantation according to types of Nucleus 24-channel electrode arrays. Acta Otolaryngol. 2009; 129 (6): 588-591. https://doi.org/10.1080/00016480802325965.

17. Battmer R., Pesch J., Stöver T., Lesinski- Schiedat A., Lenarz M., Lenarz T. Elimination of facial nerve stimulation by reimplantation in cochlear implant subjects. Otol Neurotol. 2006; 27 (7): 918-922. https://doi.org/10.1097/01.mao.0000235374.85739.c6.

18. Broomfield S., Mawman D., Woolford T. J., O’driscoll M., Luff D., Ramsden R. T. Non-auditory stimulation in adult cochlear implant users. Cochlear Implants Int. 2000; 1 (1): 55-66. https://doi.org/10.1179/cim.2000.1.1.55.

19. Frijns J. H., Kalkman R. K., Briaire J. J. Stimulation of the facial nerve by intracochlear electrodes in otosclerosis: a computer modeling study. Otol Neurotol. 2009; 30 (8): 1168-1174. https://doi.org/10.1097/MAO.0b013e3181b12115.

20. Kruschinski C., Weber B. P., Pabst R. Clinical relevance of the distance between the cochlea and the facial nerve in cochlear implantation. Otol Neurotol. 2003; 24 (5): 823-827. https://doi.org/10.1097/00129492-200309000-00022.

21. Makizumi Y., Kashio A., Sakamoto T., Karino S., Kakigi A., Iwasaki S., Yamasoba T. Cochlear implantation in a patient with osteogenesis imperfecta. Auris Nasus Larynx. 2013; 40 (5): 510-513. https://doi.org/10.1016/j.anl.2012.10.006.

22. Camilleri A. E., Toner J. G., Howarth K. L., Hampton S., Ramsden R. T. Cochlear implantation following temporal bone fracture. J Laryngol Otol. 1999; 113 (5): 454-457. https://doi.org/10.1017/s0022215100144202.

23. Maas S., Bance M., O’Driscoll M., Mawman D., Ramsden R. T. Explantation of a nucleus multichannel cochlear implant and re-implantation into the contralateral ear. A case report of a new strategy. J Laryngol Otol. 1996; 110 (9): 881-883. https://doi.org/10.1017/s0022215100135236.

24. Marshall A. H., Fanning N., Symons S., Shipp D., Chen J. M., Nedzelski J. M. Cochlear implantation in cochlear otosclerosis. Laryngoscope. 2005; 115 (10): 1728-1733. https://doi.org/10.1097/01.mlg.0000171052.34196.ef.

25. Seyyedi M., Herrmann B. S., Eddington D. K., Nadol J. B. Jr. The pathologic basis of facial nerve stimulation in otosclerosis and multi-channel cochlear implantation. Otol Neurotol. 2013; 34 (9): 1603-1609. https://doi.org/10.1097/MAO.0b013e3182979398.

26. Astashchenko S. V., Kuzovkov V. E., Ilyin S. N., Sapogovskaya A. S., Pavlova S. S. Cochlear otosclerosis: diagnostics and surgical tactics. RMJ. Medical Review. 2019; 3 (9-2): 52-55. (In Russ.) Available at: http://www.rmj.ru/articles/otorinolaringologiya/Kohlearnaya_forma_otoskleroza_diagnostika_i_taktika_hirurgicheskogo_lecheniya.

27. Kuzovkov V. E., Lilenko A. S., Sugarova S. B., Kostevich I. V. Acquired pathology of the inner ear, as a factor complicating the surgical stage of cochlear implantation. Consilium Medicum. 2018; 20 (3): 80-84. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/95065.

28. Kuzovkov V. E., Kostevish I. V., Lilenko A. S., Sugarova S. B., Nesipbaeva A. A. Surgical tactic of cochlear implantation in patients with cochlear obliteration. Tavricheskiy Mediko¬ Biologicheskiy Vestnik. 2017; 20 (3-3): 117-123. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=30014981.

29. Kuzovkov V. E., Lilenko A. S., Sugarova S. B., Lilenko S. V., Chernushevich I. I., Klyachko D. S. et al. Cochlear implantation in cochlear otosclerosis patients. Rossiiskaya Otorinolaringologiya. 2021; 20 (6): 84-92. https://doi.org/10.18692/1810-4800-2021-6-84-92.

30. Yoo T. J., Tomoda K., Stuart J. M., Kang A. H., Townes A. S. Type II collagen-induced autoimmune otospongiosis. A preliminary report. Ann Otol Rhinol Laryngol. 1983; 92 (2-1): 103-108. https://doi.org/10.1177/000348948309200201.

31. Huang C. C., Yi Z. X., Abramson M. Type II collagen- induced otospongiosis-like lesions in rats. Am J Otolaryngol. 1986; 7 (4): 258-266. https://doi.org/10.1016/s0196-0709(86)80048-5.

32. Kameda T., Mano H., Yuasa T., Mori Y., Miyazawa K., Shiokawa M. et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med. 1997; 186 (4): 489-495. https://doi.org/10.1084/jem.186.4.489.

33. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996; 11 (8): 1043-1051. https://doi.org/10.1002/jbmr.5650110802.

34. Hofbauer L. C., Khosla S., Dunstan C. R., Lacey D. L., Spelsberg T. C., Riggs B. L. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology. 1999; 140 (9): 4367-4370. https://doi.org/10.1210/endo.140.9.7131.

35. Srivastava S., Toraldo G., Weitzmann M. N., Cenci S., Ross F. P., Pacifici R. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem. 2001 Mar 23; 276 (12): 8836-8840. https://doi.org/10.1074/jbc.M010764200.

36. Raymond V., Beaulieu M., Labrie F., Boissier J. Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science. 1978; 200 (4346): 1173-1175. https://doi.org/10.1126/science.418505.

37. Charoenphandhu N., Krishnamra N. Prolactin is an important regulator of intestinal calcium transport. Can J Physiol Pharmacol. 2007; 85 (6): 569-581. https://doi.org/10.1139/y07-041.

38. Charoenphandhu N., Teerapornpuntakit J., Methawasin M., Wongdee K., Thongchote K., Krishnamra N. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats. Can J Physiol Pharmacol. 2008; 86 (5): 240-248. https://doi.org/10.1139/y08-037.

39. Seriwatanachai D., Thongchote K., Charoenphandhu N., Pandaranandaka J., Tudpor K., Teerapornpuntakit J. et al. Prolactin directly enhances bone turnover by raising osteoblast- expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio. Bone. 2008; 42 (3): 535-546. https://doi.org/10.1016/j.bone.2007.11.008.